Jasper Therapeutics (JSPR) Other Accumulated Expenses (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Other Accumulated Expenses of $120000.0 for Q4 2025, down 71.36% year-over-year from $419000.0 in Q4 2024, and up 90.48% quarter-over-quarter from $63000.0 in Q3 2025.
Jasper Therapeutics (JSPR) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $120000.0 for Q4 2025.
- In Q4 2025, Other Accumulated Expenses fell 71.36% year-over-year to $120000.0; the TTM figure through Dec 2025 stood at $120000.0 (down 71.36% YoY), while the FY2025 annual figure was $120000.0, down 71.36% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $120000.0, up from $63000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $849000.0 in Q3 2024, with the low at $63000.0 in Q3 2025.
- The 5-year median for Other Accumulated Expenses is $445000.0 (2024), against an average of $421071.4.
- The sharpest annual moves came in 2021 and 2025: Other Accumulated Expenses jumped 292.62% in 2021, then slumped 92.58% in 2025.
- Jasper Therapeutics' Other Accumulated Expenses stood at $585000.0 in 2021, then tumbled by 66.84% to $194000.0 in 2022, then jumped by 63.4% to $317000.0 in 2023, then soared by 32.18% to $419000.0 in 2024, then slumped by 71.36% to $120000.0 in 2025.
- Business Quant data shows JSPR's Other Accumulated Expenses at $120000.0 in Q4 2025, $63000.0 in Q3 2025, and $105000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 105,000.00 |
| Mar 31, 2025 | 443,000.00 |
| Dec 31, 2024 | 419,000.00 |
| Sep 30, 2024 | 849,000.00 |
| Jun 30, 2024 | 447,000.00 |
| Dec 31, 2023 | 317,000.00 |
| Dec 31, 2022 | 194,000.00 |
| Sep 30, 2022 | 816,000.00 |
| Jun 30, 2022 | 519,000.00 |
| Mar 31, 2022 | 548,000.00 |
| Dec 31, 2021 | 585,000.00 |
| Sep 30, 2021 | 470,000.00 |
| Dec 31, 2020 | 149,000.00 |